501 filings
Page 5 of 26
8-K
akm73pmtzcq1 99sz5
8 Feb 19
Other Events
5:34pm
DEFA14A
3lqh5
8 Feb 19
Additional proxy soliciting materials
5:30pm
PX14A6G
jxto7yvx8fq1ln3w5b1
8 Feb 19
Letter to shareholders
12:17pm
8-K
dihv7 bfma
29 Jan 19
Allergan Reports Fourth Quarter and Full-Year 2018 Financial Results
7:15am
8-K
e0pw n4a05
25 Jan 19
Other Events
5:07pm
8-K
gmz4om
15 Nov 18
Entry into a Material Definitive Agreement
4:31pm
8-K
d2pmfot3rdva0b5
13 Nov 18
Entry into a Material Definitive Agreement
5:03pm
424B2
4n90o3sr
9 Nov 18
Prospectus for primary offering
5:24pm
424B5
7x3cgczo
8 Nov 18
Prospectus supplement for primary offering
6:08am
8-K
vlj83
1 Nov 18
Regulation FD Disclosure
12:00am
8-K
qax28k
30 Oct 18
Allergan Reports Third Quarter 2018 Results Including GAAP Net Revenues of $3.9 Billion
6:45am
8-K
5it9fwugt4s2
29 Aug 18
Departure of Directors or Certain Officers
12:00am
8-K
5g3 pcgzk88z
8 Aug 18
Departure of Directors or Certain Officers
4:16pm
8-K
7w8wfluubdwjlxla
26 Jul 18
Allergan Reports Strong Second Quarter 2018 Results Including GAAP Net Revenues of $4.1 Billion
6:45am
8-K
c5pnm
14 Jun 18
Departure of Directors or Certain Officers
12:00am
SD
11cef7ifcla1h56or0
31 May 18
Conflict minerals disclosure
4:16pm